Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page footer’s software/site revision label was updated from v3.5.2 to v3.5.3, reflecting a minor platform maintenance change rather than any alteration to the study record content.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.3 was applied, replacing the previous v3.4.2.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded Revision: v3.4.2; removed the funding lapse notice and the previous Revision: v3.4.1. These changes pertain to site maintenance banners and do not affect study details.SummaryDifference0.4%

- Check87 days agoChange DetectedA government funding lapse notice was added to the top of the page and the revision label changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.